Niu Y - Search Results

1

The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer.

Emberley ED, Niu Y, Curtis L, Troup S, Mandal SK, Myers JN, Gibson SB, Murphy LC, Watson PH. Emberley ED, et al. Among authors: niu y. Cancer Res. 2005 Jul 1;65(13):5696-702. doi: 10.1158/0008-5472.CAN-04-3927. Cancer Res. 2005. PMID: 15994944

2

Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma.

Cooper C, Liu GY, Niu YL, Santos S, Murphy LC, Watson PH. Cooper C, et al. Clin Cancer Res. 2004 Dec 15;10(24):8720-7. doi: 10.1158/1078-0432.CCR-04-1235. Clin Cancer Res. 2004. PMID: 15623657

3

Analysis of gene expression in ductal carcinoma in situ of the breast.

Adeyinka A, Emberley E, Niu Y, Snell L, Murphy LC, Sowter H, Wykoff CC, Harris AL, Watson PH. Adeyinka A, et al. Among authors: niu y. Clin Cancer Res. 2002 Dec;8(12):3788-95. Clin Cancer Res. 2002. PMID: 12473591

4

Psoriasin interacts with Jab1 and influences breast cancer progression.

Emberley ED, Niu Y, Leygue E, Tomes L, Gietz RD, Murphy LC, Watson PH. Emberley ED, et al. Among authors: niu y. Cancer Res. 2003 Apr 15;63(8):1954-61. Cancer Res. 2003. PMID: 12702588

5

Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer.

Emberley ED, Niu Y, Njue C, Kliewer EV, Murphy LC, Watson PH. Emberley ED, et al. Among authors: niu y. Clin Cancer Res. 2003 Jul;9(7):2627-31. Clin Cancer Res. 2003. PMID: 12855640

6

Necrosis and hypoxia in invasive breast carcinoma.

Tomes L, Emberley E, Niu Y, Troup S, Pastorek J, Strange K, Harris A, Watson PH. Tomes L, et al. Among authors: niu y. Breast Cancer Res Treat. 2003 Sep;81(1):61-9. doi: 10.1023/A:1025476722493. Breast Cancer Res Treat. 2003. PMID: 14531498

7

Phospho-serine-118 estrogen receptor-alpha detection in human breast tumors in vivo.

Murphy L, Cherlet T, Adeyinka A, Niu Y, Snell L, Watson P. Murphy L, et al. Among authors: niu y. Clin Cancer Res. 2004 Feb 15;10(4):1354-9. doi: 10.1158/1078-0432.ccr-03-0112. Clin Cancer Res. 2004. PMID: 14977836

8

Phospho-serine-118 estrogen receptor-alpha expression is associated with better disease outcome in women treated with tamoxifen.

Murphy LC, Niu Y, Snell L, Watson P. Murphy LC, et al. Among authors: niu y. Clin Cancer Res. 2004 Sep 1;10(17):5902-6. doi: 10.1158/1078-0432.CCR-04-0191. Clin Cancer Res. 2004. PMID: 15355923

9

Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis.

Webb M, Emberley ED, Lizardo M, Alowami S, Qing G, Alfia'ar A, Snell-Curtis LJ, Niu Y, Civetta A, Myal Y, Shiu R, Murphy LC, Watson PH. Webb M, et al. Among authors: niu y. BMC Cancer. 2005 Feb 17;5:17. doi: 10.1186/1471-2407-5-17. BMC Cancer. 2005. PMID: 15717926 Free PMC article.

10

Estrogen receptor-alpha phosphorylated at Ser118 is present at the promoters of estrogen-regulated genes and is not altered due to HER-2 overexpression.

Weitsman GE, Li L, Skliris GP, Davie JR, Ung K, Niu Y, Curtis-Snell L, Tomes L, Watson PH, Murphy LC. Weitsman GE, et al. Among authors: niu y. Cancer Res. 2006 Oct 15;66(20):10162-70. doi: 10.1158/0008-5472.CAN-05-4111. Cancer Res. 2006. PMID: 17047081

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,449 results

Search Page

Filters